期刊
CLINICAL RESPIRATORY JOURNAL
卷 10, 期 1, 页码 104-111出版社
WILEY
DOI: 10.1111/crj.12194
关键词
biomarkers; COPD; plasma miRNAs; smoking
资金
- Chongqing Research Program [06-1-173]
- Science & Technology Department of Sichuan Province [2010JY0154]
Background and AimsWe previously showed that microRNAs (miRNAs) in plasma are potential biomarkers for cigarette smoking-related lung fibrosis. Here, we want to find out promising miRNAs for early detection of chronic obstructive pulmonary disease (COPD). Methods and ResultsPlasma miRNAs profiling was performed in COPD patients, asthma patients, and matched healthy controls. There was a >2-fold changes for all signature miRNAs between the COPD and control samples, with P values of <0.05. Pathway analysis, taking into account enriched target mRNAs for these signature miRNAs, was also carried out. We found seven miRNAs were special expression in the COPD patients. Furthermore, changes of miR-145-5p, miR-338-3p and miR-3620-3p were consistent with the classification of new ABCD classification of COPD. Targeted gene promising proved those miRNAs acted in inflammatory mediators, regulation of proliferation and differentiation, oxidative stress and so on. ConclusionsThese results suggested that plasma miRNAs could be potential specific biomarker for early detection COPD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据